Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2025-06-17 00:00:00 ET · period of report 2025-06-13 · accession 0000950170-25-087350 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-17 | 2025-06-13 | IRWD | Sarissa Capital Management LP | 10% | A - Grant | $0.00 | +24.2K | 236.0K | +11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-06-13 | A | A | 24,193 | $0.00 | 235,962 | D | — | — |